Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1983 1
1985 1
1989 1
1991 4
1992 7
1993 6
1994 8
1995 1
1996 4
1997 2
1998 1
1999 1
2001 2
2002 2
2003 3
2004 3
2005 18
2006 13
2007 20
2008 17
2009 26
2010 23
2011 24
2012 15
2013 25
2014 33
2015 21
2016 49
2017 35
2018 31
2019 30
2020 43
2021 24
2022 48
2023 34
2024 43
2025 25

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

595 results

Results by year

Filters applied: . Clear all
Page 1
XELOX (capecitabine plus oxaliplatin) plus bevacizumab (anti-VEGF-A antibody) with or without adoptive cell immunotherapy in the treatment of patients with previously untreated metastatic colorectal cancer: a multicenter, open-label, randomized, controlled, phase 3 trial.
Pan QZ, Zhao JJ, Liu L, Zhang DS, Wang LP, Hu WW, Weng DS, Xu X, Li YZ, Tang Y, Zhang WH, Li JY, Zheng X, Wang QJ, Li YQ, Xiang T, Zhou L, Yang SN, Wu C, Huang RX, He J, Du WJ, Chen LJ, Wu YN, Xu B, Shen Q, Zhang Y, Jiang JT, Ren XB, Xia JC. Pan QZ, et al. Among authors: wu yn. Signal Transduct Target Ther. 2024 Apr 3;9(1):79. doi: 10.1038/s41392-024-01788-2. Signal Transduct Target Ther. 2024. PMID: 38565886 Free PMC article. Clinical Trial.
Macrophage activation determines muscle wasting in pancreatic cancer.
Chang CJ, Huang PH, Chen SY, Su PC, Ding LY, Hou YC, Hung MN, Chen KL, Wu YN, Wu SR, Lin FC, Lu PJ, Wu HY, Chen YJ, Chang CH, Chang CP, Hwang DY, Wang YC, Shan YS. Chang CJ, et al. Among authors: wu yn. Oncogene. 2025 Aug;44(32):2797-2813. doi: 10.1038/s41388-025-03434-9. Epub 2025 May 29. Oncogene. 2025. PMID: 40442475 Free PMC article.
Low-energy extracorporeal shockwave therapy improves locomotor functions, tissue regeneration, and modulating the inflammation induced FGF1 and FGF2 signaling to protect damaged tissue in spinal cord injury of rat model: an experimental animal study.
Hsu CC, Wu KLH, Peng JM, Wu YN, Chen HT, Lee MS, Cheng JH. Hsu CC, et al. Among authors: wu yn. Int J Surg. 2024 Dec 1;110(12):7563-7572. doi: 10.1097/JS9.0000000000002128. Int J Surg. 2024. PMID: 39453843 Free PMC article.
[A new dihydrochalcone from Humulus scandens].
Wu YN, Sun B, Wang JY, Wang DZ, Song M, Zhang XQ. Wu YN, et al. Zhongguo Zhong Yao Za Zhi. 2023 Apr;48(7):1885-1891. doi: 10.19540/j.cnki.cjcmm.20221231.201. Zhongguo Zhong Yao Za Zhi. 2023. PMID: 37282964 Chinese.
In situ bidirectional human-robot value alignment.
Yuan L, Gao X, Zheng Z, Edmonds M, Wu YN, Rossano F, Lu H, Zhu Y, Zhu SC. Yuan L, et al. Among authors: wu yn. Sci Robot. 2022 Jul 13;7(68):eabm4183. doi: 10.1126/scirobotics.abm4183. Epub 2022 Jul 13. Sci Robot. 2022. PMID: 35857532
595 results